Post Top Ad
Your Ad Spot
Wednesday, June 1, 2022
Interesting study the TAME Trial
Longevity and supplements
June 01, 2022
,News

FACEBOOK
★ THE BEST DEALS OF 2023 ★











Interesting study the TAME Trial
Led
by AFAR Scientific Director Nir Barzilai, MD, these trials will test
whether those taking metformin experience delayed development or
progression of age-related chronic diseases—such as heart disease,
cancer, and dementia.
Tags
News#
Share This
Choose Your Supplements





Labels:
News
Subscribe to:
Post Comments (Atom)
Post Top Ad
Your Ad Spot
test
No comments:
Post a Comment